membro de https://brcris.ibict.br/individual/comm_ee459614-d3fc-461b-b7eb-f628e356a377 Neuroendocrinologia Clínica e Molecular Grupo de Pesquisa
publicações selecionadas Long-term Efficacy and Safety of Pasireotide in Patients With Acromegaly: 14 Years of Single-Center Real-World Experience Pituitary acting drugs: cabergoline and pasireotide Current opinion on the diagnosis and management of non-functioning pituitary adenomas gsp Mutation Is Not a Molecular Biomarker of Long-Term Response to First-Generation Somatostatin Receptor Ligands in Acromegaly The future of somatostatin receptor ligands in acromegaly Long-term, real-world experience of pasireotide dose reduction in patients with acromegaly AVALIAÇÃO DA EXPRESSÃO DOS CINCO SUBTIPOS DE RECEPTORES DE SOMATOSTATINA, DA PROTEÍNA DE INTERAÇÃO COM O RECEPTOR ARIL HIDROCARBONO E DA PROTEÍNA EM DEDO DE ZINCO QUE REGULA A APOPTOSE E A PARADA DO CICLO CELULAR EM SOMATOTROPINOMAS E SUA CORRELAÇÃO COM A RESPOSTA AO TRATAMENTO COM OS LIGANTES DOS RECEPTORES DE SOMATOSTATINA Routine Evaluation of Somatostatin Receptor Type 2 in Patients With Acromegaly: Do We Still Need More Evidence? Machine learning-based prediction model for treatment of acromegaly with first-generation somatostatin receptor ligands Telomeres length and Wnt/β-catenin pathway in adamantinomatous craniopharyngiomas miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in Acromegaly Pituitary MRI Standard and Advanced Sequences: Role in the Diagnosis and Characterization of Pituitary Adenomas Prolactinomas PERFIL DA IMUNOEXPRESSÃO DOS 5 SUBTIPOS DE RECEPTORES DA SOMATOSTATINA E DO SUBTIPO 2 DA DOPAMINA EM SOMATOTROPINOMAS: CORRELAÇÃO COM A EXPRESSÃO DO RNA MENSAGEIRO E A RESPOSTA CLÍNICA AO OCTREOTIDE-LAR Approach to the Patient: Differential Diagnosis of Cystic Sellar Lesions Apoplexy in sporadic pituitary adenomas: a single referral center experience and AIP mutation analysis
